Chongqing Daxin Pharmaceutical Co., Ltd.
FDA inspection history across 2 sites, 2015 to 2018
- 2
- Form 483s
Every document, by year
- Form 483
2015: one Form 483; 2018: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2015One Form 483, at Shuitu Town, Beibei District, China.
- 2018One Form 483, at Chongqing, China.
- 2018The longest 483 on file: 4 observations over 1 pages at Chongqing, China.
Cited most
Across all Chongqing Daxin Pharmaceutical Co. observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.160General requirements1
- 21 CFR 211.192Production record review1
- 21 CFR 211.22Responsibilities of quality control unit1
The complete Chongqing Daxin Pharmaceutical Co. file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Chongqing, China
One Form 483 · 2018 · 4 observations
Latest: Form 483, May 11, 2018 →Shuitu Town, Beibei District, China
One Form 483 · 2015 · 1 observation
Latest: Form 483, Jan 29, 2015 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2018-05-11 | 483 Form 483 | Chongqing, China | 4 | $99 |
| 2015-01-29 | 483 Form 483 | Shuitu Town, Beibei District, China | 1 | $99 |
Investigators on these documents
FEI number 3000291692 · most recent document May 11, 2018
About Chongqing Daxin Pharmaceutical Co., Ltd.
How many FDA Form 483s has Chongqing Daxin Pharmaceutical Co., Ltd. received?
FDA Intel has 2 Form 483s on file for Chongqing Daxin Pharmaceutical Co., Ltd.; the most recent is dated May 11, 2018.
When was Chongqing Daxin Pharmaceutical Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Chongqing Daxin Pharmaceutical Co., Ltd. is a Form 483 dated May 11, 2018, for the site in Chongqing, China.
What did FDA cite at Chongqing Daxin Pharmaceutical Co., Ltd.?
The regulations cited most in the observations on file for Chongqing Daxin Pharmaceutical Co., Ltd. are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.160 (General requirements), 1 time.